Translational Neuroscience: Toward New Therapies by Karoly NikolichTranslational Neuroscience: Toward New Therapies by Karoly Nikolich

Translational Neuroscience: Toward New Therapies

EditorKaroly Nikolich, Steven E. Hyman

Hardcover | August 21, 2015

Pricing and Purchase Info

$51.48 online 
$68.95 list price
Earn 257 plum® points

Out of stock online

Not available in stores


Experts from academia and industry discuss how to create a new, more effective translational neuroscience drawing on novel technology and recent discoveries.

Today, translational neuroscience faces significant challenges. Available therapies to treat brain and nervous system disorders are extremely limited and dated, and further development has effectively ceased. Disinvestment by the private sector occurred just as promising new technologies in genomics, stem cell biology, and neuroscience emerged to offer new possibilities. In this volume, experts from both academia and industry discuss how novel technologies and reworked translation concepts can create a more effective translational neuroscience.

The contributors consider such topics as using genomics and neuroscience for better diagnostics and biomarker identification; new approaches to disease based on stem cell technology and more careful use of animal models; and greater attention to human biology and what it will take to make new therapies available for clinical use. They conclude with a conceptual roadmap for an effective and credible translational neuroscience -- one informed by a disease-focused knowledge base and clinical experience.

ContributorsTobias M. Böckers, Thomas Bourgeron, Karl Broich, Nils Brose, Bruce N. Cuthbert, Ilka Diester, Gül Dölen, Guoping Feng, Richard Frackowiak, Raquel E. Gur, Stephan Heckers, Franz Hefti, David M. Holtzman, Steven E. Hyman, Nancy Ip, Cynthia Joyce, Tobias Kaiser, Edward H. Koo, Walter J. Koroshetz, Katja S. Kroker, Robert C. Malenka, Isabelle Mansuy, Eliezer, Masliah, Yuan Mei, Andreas Meyer-Lindenberg, Lennart Mucke, Pierluigi Nicotera, Karoly Nikolich, Michael J. Owen, Menelas N. Pangalos, Alvaro Pascual-Leone, Joel S. Perlmutter, Trevor W. Robbins, Lee L. Rubin, Akira Sawa, Mareike Schnaars, Bernd Sommer, Maria Grazia Spillantini, Laura Spinney, Matthew W. State, Marius Wernig

Karoly Nikolich is Consulting Professor in the Department of Psychiatry at Stanford University Medical School as well as Founder of Circuit Therapeutics and Chairman of Alkahest, two biotechnology companies that grew out of research done at Stanford. Steven E. Hyman is Harvard University Distinguished Professor of Stem Cell and Regener...
Title:Translational Neuroscience: Toward New TherapiesFormat:HardcoverDimensions:320 pages, 9 × 6 × 0.62 inPublished:August 21, 2015Publisher:The MIT PressLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0262029863

ISBN - 13:9780262029865


Editorial Reviews

A must-read volume, especially for those, like me, hoping that a very new and exciting chapter in translational neuroscience is emerging. As described in this book, it is built on a solid scientific footing -- genetics, neurocircuits, disease biology, validated cellular and animal models, and importantly, a rational data-driven nosology -- and will unquestionably deliver a new generation of highly effective medicines for some of the most disabling and fatal of human afflictions.